Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
EWTX
EWTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EWTX News
Biotech Companies Achieve Significant Milestones
4d ago
Newsfilter
Edgewise Initiates Late-Stage Trial for EDG-7500 Treatment
4d ago
seekingalpha
Edgewise Therapeutics Reports Positive Phase 2 Results for EDG-7500 in HCM Patients
4d ago
PRnewswire
Edgewise Grants Stock Options to New Employees
Jun 03 2026
PRnewswire
Servier Acquires Edgewise's Muscular Dystrophy Operations
Jun 01 2026
stocktwits
Edgewise to Sell Muscle Disease Business for $1.55 Billion
Jun 01 2026
PRnewswire
Biotech Fund Sells Erasca Stake After 700% Rally
May 18 2026
Yahoo Finance
Achieve Life Sciences Appoints Three Senior Executives
May 12 2026
Newsfilter
Cytokinetics' Heart Drug Trial Success Boosts Stock
May 05 2026
stocktwits
Edgewise Grants 72,000 Stock Options to New Employees
Apr 01 2026
PRnewswire
Edgewise Grants Stock Options to New Employees
Apr 01 2026
Yahoo Finance
Edgewise Therapeutics Stock Rises on Analyst Price Target Boost
Mar 17 2026
Fool
Analyst Raises Edgewise Price Target to $45
Mar 17 2026
NASDAQ.COM
Edgewise Presents Becker Muscular Dystrophy Study Data at MDA Conference
Mar 10 2026
PRnewswire
Edgewise Grants Stock Options to New Employees
Mar 02 2026
PRnewswire
Edgewise Grants Stock Options to New Employees
Mar 02 2026
Newsfilter
Show More News
